Oravig FDA Approval History
FDA Approved: Yes (First approved April 16, 2010)
Brand name: Oravig
Generic name: miconazole
Dosage form: Buccal Tablets
Previous Name: Loramyc
Company: BioAlliance Pharma SA
Treatment for: Oral Thrush
Oravig (miconazole) is a mucoadhesive buccal azole antifungal therapy indicated for the local treatment of oropharyngeal candidiasis in adults.
Development timeline for Oravig
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.